APSR2026-162

 
Regular
Submitted
Poster Presentation
 
AP01-002
P02
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1288/8f01e4b6fa22f85d1dbf8041d0a4542a.pdf
Format: PDF Only
02. Cell and Molecular Biology
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Gregorio Satrio Pinunggul * Saiful Anwar General Hospital Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Brawijaya University Malang Indonesia
Susanthy Djajalaksana - Saiful Anwar General Hospital Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Brawijaya University Malang Indonesia
Suryanti Dwi Pratiwi - Saiful Anwar General Hospital Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Brawijaya University Malang Indonesia
Hendy Setyo Yudhanto - Saiful Anwar General Hospital Department of Anatomy Pathology, Faculty of Medicine Brawijaya University Malang Indonesia
-
-
-
-
-
-
-
-
-
-
-
Presenting Author Details
Gregorio
Satrio Pinunggul
gregoriosatrio@gmail.com
+6282143403777
31-40
Indonesia
Original Research
The Role of Epigallocatechin Gallate Chlorogenic Acid on PPAR Gamma Levels and Pulmonary Fibrosis in a Rat Model of Metabolic Syndrome
Maximum 25 words
Abstract Content
Metabolic syndrome (MetS) increases the risk of pulmonary fibrosis through oxidative stress and activation of the transforming growth factor beta 1 pathway. Epigallocatechin gallate (EGCG) from green tea and chlorogenic acid (CGA) from green coffee possess antioxidant and antiinflammatory properties and activate the adenosine monophosphate activated protein kinase peroxisome proliferator activated receptor gamma (AMPK PPARγ) pathway. This study evaluated the effects of combined EGCG CGA on metabolic parameters, plasma and lung PPARγ expression, and pulmonary fibrosis severity in MetS rats.
A post test control group experimental design included 30 male Sprague Dawley rats randomized into control, MetS, and MetS plus EGCG CGA groups (n=10 each). MetS was induced using a high fat high sucrose diet for nine weeks. The therapy group received EGCG (300 mg/kg/day) and CGA (200 mg/kg/day) for nine weeks. Outcomes included body weight, fasting blood glucose, triglycerides, high density lipoprotein cholesterol, plasma and lung PPARγ expression measured by enzyme linked immunosorbent assay, and pulmonary fibrosis severity assessed using the Ashcroft score. Correlations were analyzed using Spearman’s test.
MetS decreased PPARγ expression in plasma (70.4%), in lung tissue (59.3%) and induced pulmonary fibrosis (Ashcroft score=5) (all p<0.001). EGCG CGA therapy significantly reduced the Ashcroft score to 4 (19.6% reduction; p=0.012). PPARγ expression increased in plasma by 279.6% (17.0±4.9 to 64.4±35.1 ng/mL; p<0.001), in lung tissue by 64.9% (27.9±4.9 to 46.0±7.2 ng/mg protein; p<0.001). A strong positive correlation was observed between plasma and lung PPARγ (rs=0.805; p<0.001), whereas strong inverse correlations were identified between PPARγ expression and fibrosis severity in plasma (rs=−0.749; p<0.001) and lung tissue (rs=−0.912; p<0.001).
Combined EGCG CGA improved metabolic profiles, enhanced systemic and pulmonary PPARγ expression, and attenuated pulmonary fibrosis in MetS, supporting its potential as a preventive and therapeutic strategy for MetS associated pulmonary complications.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
metabolic syndrome, pulmonary fibrosis, peroxisome proliferator activated receptor gamma
maximum 3 keywords and no abbreviations, separated by commas
-
336